The main shareholder of West Point Pharmaceutical (301130.SZ), Guotou Gaoke and its concerted actors have cumulatively reduced their shareholding by 1.03%.

Zhitong Finance · Dec 2 16:24

West Pharma (301130.SZ) announced that the company's shareholder, Guotou High Technology Investment Co., Ltd. (referred to as 'Guotou High-Tech'), holding more than 5% of the shares, plans to reduce its shareholding...

According to the announcement from West Pharma (301130.SZ) on Zhitong Finance APP, the company's shareholder, Guotou High Technology Investment Co., Ltd. (referred to as 'Guotou High-Tech'), and its concerted actor Hangzhou Chuanghe Selected Entrepreneurial Investment Partnership (Limited Partnership) (referred to as 'Hangzhou Chuanghe'), will collectively reduce their company's shares by 0.7865 million shares through centralized bidding and block trades from November 19, 2024, to November 29, 2024. The total reduction of shares accounts for 1.03% of the company's total share capital (excluding repurchases).

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

西点药业(301130.SZ)主要股东国投高科及其一致行动人累计减持比例达1.03%

The main shareholder of West Point Pharmaceutical (301130.SZ), Guotou Gaoke and its concerted actors have cumulatively reduced their shareholding by 1.03%.

Risk Disclaimer

Statement